Brain cells linked to Alzheimer's could open new drug treatment paths

Researchers have identified a specific receptor on brain support cells that plays a role in Alzheimer's disease, potentially offering pharmaceutical companies a new target for drug development. The finding, published in Nature Reviews Neurology, could reshape how the field approaches treating one of the world's most costly neurodegenerative diseases.

Originaltitel: The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease